American Healthcare REIT (AHR) Stock Forecast, Price Target & Predictions
AHR Stock Forecast
American Healthcare REIT stock forecast is as follows: an average price target of $24.50 (represents a -0.12% downside from AHR’s last price of $24.53) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
AHR Price Target
AHR Analyst Ratings
American Healthcare REIT Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Sep 16, 2024 | Austin Wurschmidt | KeyBanc | $27.00 | $24.58 | 9.85% | 10.07% |
Sep 03, 2024 | Michael Lewis | Truist Financial | $22.00 | $20.93 | 5.11% | -10.31% |
Jun 28, 2024 | Michael Lewis | Truist Financial | $17.00 | $14.61 | 16.36% | -30.70% |
Apr 03, 2024 | Michael Lewis | Truist Financial | $16.00 | $14.10 | 13.48% | -34.77% |
American Healthcare REIT Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 2 | 3 | 4 |
Avg Price Target | $24.50 | $22.00 | $20.50 |
Last Closing Price | $24.53 | $24.53 | $24.53 |
Upside/Downside | -0.12% | -10.31% | -16.43% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Sep 16, 2024 | KeyBanc | Overweight | Overweight | Hold |
Aug 22, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
Aug 07, 2024 | JMP Securities | Outperform | Outperform | Hold |
May 16, 2024 | RBC Capital | Underperform | Underperform | Hold |
May 16, 2024 | Truist Financial | Market Outperform | Market Outperform | Hold |
Apr 03, 2024 | Truist Financial | Market Outperform | Market Outperform | Hold |
Apr 03, 2024 | RBC Capital | Underperform | Underperform | Hold |
Mar 04, 2024 | RBC Capital | - | Outperform | Initialise |
Mar 04, 2024 | JMP Securities | - | Market Outperform | Initialise |
American Healthcare REIT Financial Forecast
American Healthcare REIT Revenue Forecast
Revenue |
Avg Forecast |
High Forecast |
Low Forecast |
# Analysts |
Surprise % |
American Healthcare REIT EBITDA Forecast
# Analysts |
EBITDA |
Avg Forecast |
High Forecast |
Low Forecast |
Surprise % |
American Healthcare REIT Net Income Forecast
# Analysts |
Net Income |
Avg Forecast |
High Forecast |
Low Forecast |
Surprise % |
American Healthcare REIT SG&A Forecast
# Analysts |
SG&A |
Avg Forecast |
High Forecast |
Low Forecast |
Surprise % |
American Healthcare REIT EPS Forecast
# Analysts |
EPS |
Avg Forecast |
High Forecast |
Low Forecast |
Surprise % |
AHR Forecast FAQ
Is American Healthcare REIT a good buy?
Yes, according to 4 Wall Street analysts, American Healthcare REIT (AHR) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 100.00% of AHR's total ratings.
What is AHR's price target?
American Healthcare REIT (AHR) average price target is $24.5 with a range of $22 to $27, implying a -0.12% from its last price of $24.53. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will American Healthcare REIT stock go up soon?
According to Wall Street analysts' prediction for AHR stock, the company can go down by -0.12% (from the last price of $24.53 to the average price target of $24.5), up by 10.07% based on the highest stock price target, and down by -10.31% based on the lowest stock price target.
Can American Healthcare REIT stock reach $40?
AHR's average twelve months analyst stock price target of $24.5 does not support the claim that American Healthcare REIT can reach $40 in the near future.
What is American Healthcare REIT's current price target trend?
2 Wall Street analysts forecast a $24.5 price target for American Healthcare REIT (AHR) this month, down -0.12% from its last price of $24.53. Compared to the last 3 and 12 months, the average price target decreased by -10.31% and decreased by -16.43%, respectively.